annb0t
Top 20
MELBOURNE, Australia and LIÃGE, Belgium, April 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces agreements with Sociedade Avanço, Unipessoal, LDA (Avanço) and THP Medical Products Vertriebs GmbH (THP) for the distribution of Telix's prostate cancer investigational imaging product Illuccix® (Kit for the preparation of gallium-68 (68Ga) gozetotide (also known as PSMA-11) injection) for the Portuguese and Austrian, Czech Republic and ...
>>> Read more: Telix Further Strengthens European Distribution Network for Illuccix
>>> Read more: Telix Further Strengthens European Distribution Network for Illuccix
